Vir Biotechnology Announces Chief Financial Officer Transition
Friday, July 24, 2026 1 min read
Key Takeaway: Vir Biotechnology has announced a leadership transition with Brent Sabatini appointed as the Interim Principal Financial Officer. This change follows the departure of Jason O'Byrne, who will assist in the transition until August 3. The company is now conducting a search for a permanent CFO.
Market Sentiment Analysis
POSITIVE FACTORS
Brent Sabatini has been appointed Interim Principal Financial Officer.
The transition aims for a smooth handover with Jason O'Byrne's assistance.
Vir Biotechnology is actively searching for a new CFO.
Full Press Release Details
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Brent Sabatini, Senior Vice President and Chief Accounting Officer, has been appointed Interim Principal Financial Officer, effective July 23. Jason O’Byrne is leaving the Company to pursue another opportunity and will remain with Vir Biotechnology through August 3 to ensure a smooth transition. The Company has initiated a comprehensive search to identify its next Chief Financial Officer."Brent has deep in
Frequently Asked Questions
Who is the new Interim Principal Financial Officer at Vir?
Brent Sabatini has been appointed as the Interim Principal Financial Officer.
Why is Jason O'Byrne leaving Vir Biotechnology?
Jason O'Byrne is leaving to pursue another opportunity.
When will Jason O'Byrne's departure take effect?
His departure will take effect on August 3.
Is Vir Biotechnology searching for a new CFO?
Yes, the company has initiated a search for its next Chief Financial Officer.